Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Huvudupphovsman: | Tamanna, Mst. Taskia |
---|---|
Övriga upphovsmän: | Sharmin, Dr. Sabrina |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2023
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/18146 |
Liknande verk
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
av: Hassan, Md. Muhtaz
Publicerad: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
av: Islam, Md. Irfath
Publicerad: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
av: Alim, Abdul
Publicerad: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
av: Parveen, Sanjana
Publicerad: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
av: Tabassum, Nadira
Publicerad: (2024)